Background-Increased sympathetic outflow is a major contributor to the progression of chronic heart failure (CHF).
D
uring chronic heart failure (CHF), blood supply to the brain may be compromised. A relative or imperceptibly subtle change of blood flow to specific brain area may result in an oxygen deficiency, possibly characterized as a mild hypoxic state. Hypoxia is known to induce changes at the molecular level within cells. The first adaptive cellular response to hypoxia involves the upregulation and stabilization of hypoxia-inducible factor-1 (HIF-1), a major transcription factor involved in gene regulation under low oxygen environment. HIF-1 is a heterodimer of HIF-1α and HIF-1β subunits. In physiological conditions, the HIF-1β subunit is constitutively expressed, and the HIF-1α subunit is present at relatively low levels because of continuous proteolysis through an oxygen-dependent ubiquitin-proteasome pathway.
1 HIF-1α is subjected to hydroxylation on proline residues via prolyl hydroxylase enzyme under normoxic conditions. Hydroxylation is a prerequisite for the binding of the pVHL (von Hippel-Lindau) tumor suppressor protein, an E3 ubiquitin protein ligase, which targets HIF-1α for proteasomal degradation. Under hypoxic conditions, prolyl hydroxylase catalytic activity is inhibited, and the pVHL protein does not bind to HIF-1α, ultimately leading to stabilization of the α-subunit. Once stabilized, this heterodimer of HIF-1α and HIF-1β translocate to the nucleus and is capable of binding to hypoxia response elements in promoter sequences of genes involved in angiogenesis, erythropoiesis, glycolysis, iron metabolism, and cell survival. 
See Clinical Perspective
Hypothalamic paraventricular nucleus (PVN) of the brain is vital for cardiovascular regulation 3, 4 and is responsive to hypoxic stress. 5 Neurons within the PVN are regulated NMDA-NR1 Response to Hypoxia by glutamate, as an excitatory neurotransmitter, 6 and nitric oxide, 7, 8 as an inhibitory regulator. Disturbances in these homeostatic mechanisms can alter the sympathetic tone and are exasperated in disease conditions such as hypertension and CHF. 7, 9 It has been shown that during CHF an increase in glutamatergic activity via an upregulation of the NMDA-NR 1 (N-methyl-D-aspartate type 1) subunit of the NMDA receptor, at transcriptional and translational level, plays an important role in increasing the sympathoexcitation. 6 NMDA receptors (NMDARs) are hetero-oligomeric proteins and are composed of the essential NMDA-NR 1 structural subunit, NR 2 subunits (A-D), and NR 3 subunit (A and B). [10] [11] [12] Incorporation of NR 2 subunit depends on the age and region of brain. 11, 13 NR 3 subunit functions as a negative modulator of the receptor. 12, 14 Overactivation of NMDAR can result in neuronal excitotoxicity and neuronal cell death because of intracellular accumulation of calcium, leading to brain injury and possible chronic neurodegenerative disorder. The molecular mechanism responsible for this upregulation of NMDA-NR 1 remains unclear. NMDARs are subjected to multiple levels of regulation, including transcriptional 10 and post-transcriptional, involving phosphorylation and dephosphorylation by kinase and phosphatases. 15 Being an obligatory subunit of NMDAR, the molecular mechanisms of NMDA-NR 1 subunit regulation are fundamental to receptor function. We hypothesize that the HIF-1 transcriptional complex accumulation may be regulating/modulating the function of NMDAR in CHF. Therefore, the present study was undertaken to investigate the effect of HIF-1α stabilization on NMDA-NR 1 expression in CHF.
Methods

CHF Model
Male Sprague-Dawley rats weighing 220 to 240 g were fed and housed according to approved guidelines of the University of Nebraska Medical Center Institutional Animal Care and Use Committee, which conform to the Guide for the Care and Use of Laboratory Animals, Eighth Edition (National Academic Press; 2011). Rats were randomly assigned to either the sham-operated group or the CHF group and were ventilated at a rate of 60 breaths per minute with 2% to 3% isoflurane during the surgical procedure. CHF was induced by ligation of the left coronary artery, which has been described previously 8 and is extensively used in our laboratory. [16] [17] [18] [19] This myocardial infarct model mimics the most common cause of CHF in humans. Left ventricular dysfunction and heart failure were assessed using hemodynamic and anatomic criteria. Rats with elevated left ventricular end-diastolic pressure (>15 mm Hg), infarct size (>35% of total left ventricle wall), and significant reductions in dp/dt max were considered to be in CHF (Table) . Experiments were performed on the rats 6 to 8 weeks after the coronary artery ligations.
Immunohistochemistry Staining for HIF-1α in Sections of the PVN
Immunohistochemistry was performed for HIF-1α in coronal sections of the PVN from Sham and CHF groups. Rats were anesthetized with pentobarbital (65 mg/kg) and perfused transcardially with 150 mL of heparinized saline followed by 250 mL of 4% paraformaldehyde in 0.1 mol/L sodium phosphate buffer. The postfixing of brains were done in 4% paraformaldehyde solution at 4 °C for 4 hours followed by 20% sucrose. The brain was blocked in the coronal plane, and 10-µm sections were cut using a cryostat, mounted on slides, and subjected to immunofluorescence (see Data Supplement for details).
Real-Time Polymerase Chain Reaction and Western Blotting for HIF-1α in the PVN
After euthanasia, the brain was removed and quickly frozen on dry ice. Six serial coronal sections (100 μm) were cut using a cryostat, and following the Palkovits 20 technique, the PVN was bilaterally punched using a diethylpyrocarbonate-treated blunt 18-gauge needle attached to a syringe and processed as described previously 8 (see Data Supplement for details).
Induction of Hypoxia in NG108 Cells
We followed the modified protocol of Wright and Shay 21 to create hypoxia in cultured NG108 cells (see Data Supplement for details).
Intracellular Calcium Concentration Changes to Glutamate
Subconfluent NG108 cells were grown on Nunc Laboratory-Tek chambers and were exposed to hypoxia for 12 hours before experimentation. Glutamate-stimulated changes in intracellular calcium concentration ([Ca2+]i) in NG108 cells were assessed using fluo-3 (Invitrogen) fluorescence imaging using a Zeiss LSM 510 META confocal microscope (see Data Supplement for details).
siRNA Knockdown of HIF-1α
siRNA targeting HIF-1α (sc-45919), a negative control siRNA (sc-37007), was purchased from Santa Cruz Biotechnology, Inc. Transient transfection was performed in NG108 cells (2×105 cells) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) as per the manufacturer's instructions and as detailed in Data Supplement.
Chromatin Immunoprecipitation Assay to Confirm HIF-1 Binding to NMDA-NR 1 The chromatin immunoprecipitation assay was performed in NG108 cells after 4 hours of hypoxia because at this point NMDA-NR 1 mRNA starts showing an increase (see Data Supplement for details).
Other Measurements and Analyses
Methods for real-time polymerase chain reaction, western blot, and immunofluorescent microscopy of NG108-15 cells are described previously 22 (see Data Supplement for details). In vivo HIF-1α siRNA transfer was performed according to the method described by Chen et al, 23 50 pmol of HIF-1α siRNA (Santa Cruz; sc-45919) was diluted with the same volume of Lipofectamine 2000 and incubated for 45 minutes at room temperature (25 °C). HIF-1α siRNA-lipid complexes (200 nL) were injected bilaterally into the PVN using a Hamilton microsyringe under a guidance of stereotaxic instrument (Kent Scientific Corporation) in anesthetized rats.
Hemodynamic and Renal Sympathetic Nerve Activity Measurements
Rats were anesthetized with urethane (0.75 g/kg IP) and α-chloralose (70 mg/kg IP). Renal sympathetic nerve activity (RSNA) was monitored in the 4 groups of rats: sham, CHF, sham+HIF-1α siRNA, and CHF+HIF-1α siRNA after 6-8 hours of injection as described before, 6, 8, 18, 19 and greater details are provided in the Data Supplement.
Statistical Analyses
Data are expressed as mean±SEM. Differences between groups and among groups were assessed by t test (with and without Welch correction) and 1 or 2-way ANOVA followed by Holm Sidak multiple comparisons test for post hoc analysis of significance (Prism 7; GraphPad Software). Additional specific details are provided in the Data Supplement. P<0.05 was considered to indicate statistical significance.
Results
Expression of HIF-1α in the PVN During CHF
Immunohistochemistry staining for HIF-1α expression in the PVN from a sham and CHF rat are shown in Figure 1A .
HIF-1α-positive staining was observed in the parvocellular and the magnocellular regions of the PVN. There was a distinct upregulation of HIF-1α immunolabeling in the PVN sections from CHF rats compared with sham rats. Quantification of reciprocal intensity, 24 as mentioned above, revealed that there was a significant increase in DAB staining in the PVN of CHF rats, suggesting an increase in HIF-1α expression. Figure 1C shows that HIF-1α mRNA levels (normalized to levels of RPL: ribosomal protein L19) were elevated ≈9-fold in the PVN of CHF rats relative to the Sham rats. Furthermore, Western blotting for HIF-1α in the PVN punches corroborates our immunohistochemistry results showing a 2.4-fold upregulation of HIF-1α in CHF compared with sham (0.18±0.03 versus 0.43±0.01*; Figure 1D ).
Changes in HIF-1α Expression in Response to Hypoxia in NG108 Cells
To understand the effect of hypoxia on HIF-1α expression, NG108 cells were challenged to hypoxia. Figure 2A shows that after 2 hours of hypoxia, HIF-1α protein levels (normalized to GAPDH) started to increase; however, we observed a statistically significant increase in 4 hours (1.48±0.19-fold change), with a continual increase at 8 and 12 hours (1.55±0.22-fold and 1.99±0.28-fold changes, respectively). No significant differences were observed between HIF-1α mRNA levels in control and hypoxic cells ≤2 hours (Figure 2B ). However, transient but not significant increases of 32% and 42% were observed at 4 and 8 hours followed by a decrease at 12 hours, suggesting that hypoxia does not have any significant effect on mRNA of HIf-1α. It is possible that the control of HIF-1α expression in the NG108 cells is principally post-transcriptional, most likely at the level of protein degradation. Figure 2C shows that 1 hour of normoxia after 12 hours of hypoxia significantly reduces the levels of HIF-1α, suggesting the reversibility and a role for oxygen-sensing machinery in the regulation of HIF-1α.
Changes in NMDA-NR 1 Expression to Hypoxia in NG108 Cells
The NMDA-NR 1 promoter sequence has at least one known HIF-1 transcription complex-binding site. 25 This suggests that the HIF-1 transcription complex may bind to the NMDA-NR 1 promoter and increase transcription of NMDA-NR 1 . Our real-time polymerase chain reaction revealed that after half an hour of hypoxia, NMDA-NR 1 levels were elevated ≈2-fold relative to the control ( Figure 3A) . A statistically significant increase was observed at hypoxic time points of 4, 8, and 12 hours, and after that, it started to decrease. In accord with changes in mRNA, protein expression of NMDA-NR 1 subunit started to increase at 4 hours and reached statistically significant level after 12 hours of hypoxia exposure (1.42±0.23-fold change; Figure 3B ).
Immunofluorescent Staining of HIF-1α and NMDA-NR 1 in NG108 Cells
To further corroborate these expression data, we stained NG108 cells for HIF-1α and NMDA-NR 1 after 0 and 12 hours of hypoxia ( Figure 3C ). Representative micrograph of stained neurons revealed an increase in both HIF-1α and NMDA-NR 1 expression after 12 hours of hypoxia. Weak immunofluorescence of HIF-1α was detected in the cytoplasm of NG108 cells grown in normoxia; however, on hypoxic exposure, there was a dramatic increase in HIF-1α levels that was observed to translocate to the nucleus. In the merged high-magnification image, HIF-1α was clearly identified in nucleus stained in dark pink. Similar to HIF-1α, NMDA-NR 1 immunostaining was also increased in response to hypoxia ( Figure 3D ).
Functional Responses of Activating NMDAR After Hypoxia in NG108 Cells
To assess the functional significance of changes in expression of NMDAR during hypoxia, glutamate-stimulated NMDAR-mediated increase in intracellular calcium ([Ca 2+ ] i influx) was monitored in NG108 cells that were exposed to hypoxia for 12 hours using Fura 2 confocal live cell imaging technique 26 
HIF-1α Regulates NMDA-NR 1 Receptors in NG108 Cells
To further test the hypothesis that HIF-1 transcription factor may be regulating NMDA-NR 1 upregulation, we used 2 approaches: (1) chromatin immunoprecipitation assay and (2) siRNA-mediated targeting of HIF-1α. Chromatin immunoprecipitation assay revealed that compared with the control, the binding of HIF-1 transcription complex to NMDA-NR 1 promoter was increased 3.2-fold in cells exposed to 4 hours of hypoxia ( Figure 5A ). Next, NG108 cells were transfected with either HIF-1α-siRNA or with a scrambled siRNA. Four pmol of siRNA showed a slight but not significant decrease in HIF-1α and NMDA-NR 1 protein levels compared with the scrambled siRNA, whereas 8 pmol of siRNA showed ≈57% decrease in HIF-1α protein expression and a 64% decrease in NMDA-NR 1 protein expression compared with the scrambled siRNA, suggesting a potential role for HIF-1α in the regulation of NR 1 subunit ( Figure 5B ).
NMDA-Mediated Sympathoexcitatory Responses From the PVN After Silencing HIF-1α
To translate our in vitro findings to whole animal functional studies, we assessed the effects of in vivo HIF-1α silencing on NMDAR-mediated sympathoexcitation from the PVN. RSNA, mean arterial pressure (MAP), and heart rate (HR) were recorded after siRNA HIF-1α microinjection in the PVN ( Figure 6 ). Typical tracings of the RSNA, MAP, and HR responses to the administration of NMDA (200 pmol) into the PVN in the 4 groups of rats (sham, sham+HIF-1α siRNA, CHF, CHF+HIF-1α siRNA) are shown in Figure 6A . Basal value (calculated as the absolute value or as the percent of maximum change) 28, 29 was significantly higher in CHF rats compared with the sham rats ( Figure 6B ). Silencing of HIF-1α significantly reduced baseline RSNA in rats with CHF, suggesting that there is a tonic effect of elevated levels of HIF-1α to increased sympathetic tone in rats with CHF. As reported earlier, RSNA, MAP, and HR responses to microinjection of NMDA into the PVN were significantly augmented in CHF rats as compared with sham rats (RSNA: 57 suggesting that the increased expression of HIF-1α in CHF rats may have stimulatory effect on NMDAR-mediated functional responses. The vehicle control (100 nL artificial cerebrospinal fluid) microinjected into the PVN had no effects on RSNA, MAP, and HR.
Discussion
In the present study, we showed that there was an increased expression of HIF-1α, a transcriptional regulator of the cellular adaptation to hypoxia, within the PVN of rats with CHF. We also showed that, in neuronal cells exposed to hypoxia, HIF-1α and NMDA-NR 1 subunit of NMDAR are concomitantly upregulated. This increase in NMDA-NR 1 expression was shown to be functionally effective as there was an increase in NMDAR-mediated intracellular calcium in neuronal cells exposed to hypoxia. Conversely, HIF-1α silencing in neuronal cells decreased the expression of NMDA-NR 1 subunit. Translating this to the whole animal studies, we showed that HIF-1α siRNA knockdown within the PVN of rats with CHF abrogated the enhanced basal renal sympathetic tone in rats with CHF. Furthermore, HIF-1α siRNA administration into the PVN ameliorated the increased RSNA, MAP, and HR responses to NMDA in rats with CHF. The HIF proteins are among the most rapidly degrading proteins ever studied. The half-life of HIF-1α protein is ≈5 to 8 minutes under normal oxygenated conditions. 30 Rapid uptake of siRNA (saturated at 1 hour) was reported in primary culture from hippocampus, 31 leading to reduction in target mRNA levels. We think that localized HIF1-α siRNA delivery to the PVN decreases the fresh transcription of HIF1-α, whereas the existing cytoplasmic pool of the HIF1-α is removed by proteasomal degradation resulting in faster depletion of HIF1-α. This suggests that there is, although a subtle but significant, effect of hypoxia within specific sites such as the PVN, such that a hypoxic environment for neurons stabilizes HIF-1α, which binds to constitutively expressed HIF-1β to form the HIF-1 transcription complex. This transcription complex then promotes transcription of NMDA-NR 1 leading to increased protein expression, which leads to enhanced tonic effects of glutamatergic activation of preautonomic neurons within the PVN to cause enhanced sympathetic activity in CHF (Figure 7) .
We have used neuroblastoma×glioma hybrid clone NG108-15 as our in vitro neuronal cell model that was derived by fusion of mouse neuroblastoma clone N18TG6 with rat glioma clone C6BU1. NG108 cells have neuronal properties and also have endogenous expression of nNOS 8 and NMDAR 22, 32 components of the regulatory mechanisms that are also present in preautonomic neurons within the PVN. Thus, these cells were used to serve as a suitable surrogate for an in vitro neuronal cell model for our studies.
Overexpression of the glutamatergic NMDARs leads to increased sympathoexcitation and subsequent ]i) represented as arbitrary intensity units of control and hypoxia group at basal and after glutamate stimulation at 42 s, which is the time point showing maximum Fura 2 intensity in most of the neurons (n=20-22 cells from 3 coverslips in each group). *P=0.001 after glutamate stimulation compared with basal levels in control group. $P=0.001 after glutamate stimulation compared with basal levels in hypoxia group.
# P=0.003 after glutamate stimulation hypoxic group vs control group. NMDA-NR1 Response to Hypoxia pathophysiological progression of disease states such as hypertension and heart failure. Hypoxic conditions in the brain can result from ischemic heart disease, stroke, cancer, chronic lung disease, and congestive heart failure. 33 HIF-1 consists either of HIF-1α or HIF-2α, which is oxygen regulated, and the constitutively expressed β-subunit termed HIF-1β, which are basic helix-loop-helix proteins of the PAS (Per, ARNT, Sim) family. 34 Although it has long been assumed that blood flow to the brain remains relatively unchanged during heart failure, 35 small imperceptible changes in blood flow to areas of the brain highly vascularized (such as the PVN) could induce subtle but slight hypoxia in these areas. This relative hypoxia may lead to stabilization of HIF-1α and therefore promote transcription of HIF-1-targeted genes. The molecular mechanism proposed in this study implies that the HIF-1 transcription complex may function as a central signal in the upregulation of the NMDA-NR 1 in hypoxic conditions. Two hypoxia response elements, designated as HRE1 and HRE2, were identified via a computer-based analysis of NMDA-NR 1 promoter sequence (NCBI accession no. NM017010). 25 These elements containing the core sequence 5′-RCGTG-3′ were located between −473 and −356 bp upstream of the translation start site of the NMDA-NR 1 gene and function as putative HIF-1 transcription factor-binding sites. Further studies are necessary to determine whether the HIF-1 transcription complex is solely mediating this sympathoexcitation or is a contributory component of the overall sympathoexcitation that is commonly observed in CHF. Furthermore, we did not see increased HIF-1α expression in adjacent regions such as supraoptic nucleus ( Figure I in the Data Supplement) but that does not preclude the possibility that HIF-1α could be increased in areas of the brain responsible for generation of sympathetic outflow using the NMDA receptors, such as rostral ventrolateral medulla in the brain stem.
In the present studies, we observed significant increases in the HIF-1α transcript and protein levels, which lead us to speculate that in the PVN of these CHF rats, the HIF-1α transcription, and translation, may get affected. Under normoxic conditions, HIF-1α is proline hydroxylated leading to a conformational change that promotes binding to the pVHL; E3 ligase complex followed by ubiquitination and proteasomal degradation. 1 In addition to oxygen-dependent degradation via ubiquitin-proteasome pathway, oxygen-independent degradation was reported by the chaperone Hsp90 inhibitor geldanamycin 36 and p53-Mdm2 complex. 37 Both hypoxic conditions and chemical hydroxylase inhibitors (such as desferrioxamine and cobalt) inhibit HIF-1α degradation and lead to its stabilization. 38, 39 In contrast to protein stabilization, many investigators observed that HIF-1α mRNA levels increased after prolonged hypoxia, 40, 41 and also HIF-1α can be induced in an oxygen-independent manner by neurohumoral activators such as angiotensin II (AngII), 42, 43 growth factors, and cytokines. 44, 45 It is possible that the increased level of HIF-1α mRNA in the PVN of CHF rats that we have observed may be because of other factors such as AngII and cytokines that are also known to be elevated in CHF.
. 46, 47 AngII has been shown to induce expression of HIF-1α 48 and NMDA-NR 1 AngII. Perhaps, increased levels of AngII in CHF may be a contributory factor for the increased transcription of HIF-1 α and hence increased NMDAR-mediated sympathoexcitation. The contribution of the AngII and cytokine systems within the PVN on HIF-1α levels in rats with CHF remains to be examined. As discussed above, HIF-1α is not only regulated at post-transcriptional level but also at the transcriptional level via signaling pathways. A cross talk between the nuclear factor (NF)-κB and HIF signaling pathways has also been reported. The different NF-κB subunits bind to the HIF-1α promoter 49 to activate HIF-1α transcription. Tumor necrosis factor-α-induced HIF-1α expression is dependent on NF-κB activation, and NF-κB silencing leads to reduced level of HIF-1α mRNA. 49 AngII is known to activate NF-κB in the catecholaminergic CATH.a neurons, and the upregulation of AT 1 receptor gene transcription in response to AngII is initiated by cAMP response element binding protein/NF-κB activation and propagated via downstream transcription factors Elk-1 and c-Fos. 50 NF-κB and c-Fos have been proposed as key molecules in the pathophysiology of heart failure and hypertension, 51 suggesting that perhaps these transcription factors are likely playing a critical role in HIF-1 α activation in the PVN during heart failure. In the ligandinduced activation of HIF-1, two major phosphorylation pathways are involved, the phosphatidylinositol-3-kinase and the mitogen-activated protein kinase pathways. 52 In present studies, the increase in HIF-1α mRNA levels that we observed may be through AngII-mediated activation of mitogen-activated protein kinase pathways. Additional experiments with AngII-infused rat models would address these questions more specifically.
The sympathetic nervous system has been the focus of investigation and target for intervention in CHF. 53 It has since been realized that sympathetic activity in CHF can be both beneficial and harmful. Moxonidine, which acts centrally through the imidazoline receptors to decrease sympathetic outflow, was associated with increased mortality, despite a significant reduction in plasma norepinephrine, at least in patients with severe CHF (MOXCON trial [Moxonidine Congestive Heart Failure]). 54 Thus, it has been suggested that modulation of sympathetic activity may remain an objective in this area but perhaps only in patients with moderate CHF in whom the enhanced sympathetic activity is probably deleterious. Our previous work has identified the PVN and specifically the imbalance between the excitatory glutamatergic and inhibitory NO mechanisms within this site to lead to detrimental sympathoexcitation in heart failure. 6, 53, 55 Furthermore, our recent studies have used the efficacy of exercise training (4, 5, 6) 19,56,57 and renal denervation 58 to reduce sympathoexcitatory drive (interestingly appropriately without the adverse effects such as those observed in the MOXCON trial) to examine the changes in central mechanisms specifically within the PVN to identify a potential therapeutic target. Thus, recognizing the contribution of HIF-1α and NMDA receptors represent some new potential therapeutic targets for future clinical interventions to appropriately reduce sympathoexcitation without the detrimental effects. These results provide the insight into the possible underlying mechanisms that result in the beneficial effects of both exercise training and renal denervation. 19, 58 In conclusion, we demonstrated that HIF-1α expression in the PVN of CHF rats was increased leading to exaggerated NMDAR-mediated sympathoexcitation. Furthermore, dissecting the molecular pathway involved in upregulation of HIF-1α in the PVN during CHF may help to identify novel therapeutic targets to alleviate the sympathoexcitation. Pharmacological and gene therapy strategies designed to modulate HIF-1α activity may represent a novel and effective therapeutic approaches to alleviate the sympathoexcitation commonly seen in the CHF condition. by hypoxia-inducible factor 1 (HIF-1) in the paraventricular nucleus (PVN) in chronic heart failure (CHF). Hypoxia induces upregulation of HIF-1α, which binds to constitutively expressed HIF-1β to form the HIF-1 transcription complex. This transcription complex binds to the HRE1 and HRE2 located in the promoter of NMDA-NR 1 , leading to increased expression of NMDA-NR 1 in the PVN during CHF causing an increase in sympathetic nerve activity.
